EUVIMEDEUVIMED entdecken
Crossref

Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome: An Intertwined Epidemic

Journal of Pathology and Diagnostic Microbiology · 2024 · 1

DOI: 10.59462/jpdm.1.1.103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pathology and Diagnostic Microbiology, 2024.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome (MetS) are two interconnected health conditions that have become increasingly prevalent worldwide. NAFLD is characterized by excessive fat accumulation in the liver, while MetS is a cluster of conditions including obesity, insulin resistance, hypertension, and dyslipidemia. The two conditions share common pathophysiological mechanisms and risk factors, and individuals with NAFLD are more likely to develop MetS and vice versa. The growing burden of NAFLD and MetS poses significant challenges to global health, highlighting the need for a comprehensive understanding of their relationship and effective management strategies.

Zitieren

APA

(2024). Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome: An Intertwined Epidemic. Journal of Pathology and Diagnostic Microbiology, 1. https://doi.org/10.59462/jpdm.1.1.103

Vancouver

Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome: An Intertwined Epidemic. Journal of Pathology and Diagnostic Microbiology. 2024;1. doi:10.59462/jpdm.1.1.103

BibTeX
@article{euvimed2024,
  title = {Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome: An Intertwined Epidemic},
  journal = {Journal of Pathology and Diagnostic Microbiology},
  year = {2024},
  volume = {1},
  doi = {10.59462/jpdm.1.1.103}
}
Kostenlos starten →